Viz.ai Stock

www.viz.aiHealthcare / Healthcare softwareFounded: 2016Funding to Date: $253.45MM

Viz.ai, founded in 2016, is an AI-driven modern care coordination technology designed to improve how healthcare is delivered. The Viz Platform features advanced deep learning software that analyzes medical imaging, aiming to accelerate a diagnosis, and increase the speed of diffusion of medical innovation.

Register To Buy and Sell Shares

For more details on financing and valuation for Viz.ai, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Viz.ai’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Viz.ai.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Chris Mansi
Co-Founder, Chief Executive Officer & Board Member
Julie Skaff
Chief Operating Officer
David Golan
Co-Founder, Chief Technology Officer & Board Member
Gad Sakin
Chief Product Officer and General Manager
Kurt Blasena
Chief Revenue Officer
Jayme Strauss
Chief Clinical Officer
David Kizner
Chief Privacy Officer & General Counsel
Jieun Choe
Chief Marketing Officer

Board Members

Mamoon Hamid
Kleiner Perkins
Kevin Ding
DHVC
Neil Shah
Greenoaks Capital Partners
Nikhil Sachdev
Insight Partners
Rory O'Driscoll
Scale Venture Partners

Frequently Asked Questions About Viz.ai’s Stock

plusminus
Can you buy Viz.ai’s stock?
Viz.ai is not publicly traded on NYSE or NASDAQ in the U.S. To buy Viz.ai’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Viz.ai’s stock?
Yes, you can sell stock of a private company like Viz.ai. Forge can help you sell your Viz.ai stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Viz.ai’s stock price?
Viz.ai is a privately held company and therefore does not have a public stock price. However, you may access Viz.ai’s private market stock price with Forge Data.
plusminus
What is Viz.ai’s stock ticker symbol?
Viz.ai does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

AI model for HCM, the first of its kind, gains FDA approval
Viz.ai has received a de novo approval from the U.S. Food and Drug Administration (FDA) for its new artificial intelligence (AI) algorithm designed to identify signs of hypertrophic cardiomyopathy (HCM) in routine electrocardiograms (ECGs).
Viz.ai announces study findings demonstrating real-world impact of AI-driven stroke technology
Viz.ai has presented three new studies demonstrating the real-world impact of its AI-driven stroke technology. The studies highlight the superior performance of the Viz LVO solution in detecting large vessel occlusion on CT angiography for acute stroke, the value of data in visualising disparities in care and redistributing resources to increase access to stroke care in rural areas, and the successful implementation of Viz.ai's AI-powered solutions to assess and treat chronic subdural haematoma patients.
Viz.ai Joins the World Economic Forum as a Unicorn in the Innovator Communities
Named a Unicorn sub-community member, Viz.ai will be offering unique insights and solutions to global healthcare-related issues and how to harness the power of artificial intelligence for common good.
Updated on: Apr 14, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.